Genetic Signatures | GSS - Operating Profit

Stock Price
0.15
Daily Change
0 0%
Monthly
-39.58%
Yearly
-74.22%
Q1 Forecast
0.15

Genetic Signatures reported AUD-15.16M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Avita Medical AUD -11.15M 1.19M Jun/2025
Medical Developments International AUD -480K 662K Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
Starpharma Holdings AUD -2.3M 3.09M Jun/2025
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024